Senior insider sale
Chief Scientific Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$763.39
787.00 shares
What this filing means
TAVERAS ARTHUR plans to sell 787.00 shares of X4 PHARMACEUTICALS, INC valued at approximately $763.39. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2024ACC: 0001973141-24-000107
Officer· Chief Scientific Officer
Since Nov 2020
787.00
Shares to sell
$763.39
Approx. market value
787.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
N/A
2/12/2024
787.00Total acquired787.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Stock Award N/A | 787.00 | — |
| Total | 787.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
787.00
Market value
$763.39
2/12/2024
Total
Units
787.00
Value
$763.39
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/12/2024 | 787.00 | $763.39 | NASDAQ | Planned |
| Total | 787.00 | $763.39 | ||